• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW, INC. 44MM COCR MODULAR HEAD; PROSTHESIS, HIP, SEMI-CONSTRAINED, UNCEMENTED, METAL/POLYMER, POROUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW, INC. 44MM COCR MODULAR HEAD; PROSTHESIS, HIP, SEMI-CONSTRAINED, UNCEMENTED, METAL/POLYMER, POROUS Back to Search Results
Model Number 71342644
Device Problem Biocompatibility (2886)
Patient Problems Hip Fracture (2349); Osteolysis (2377); Metal Related Pathology (4530)
Event Date 08/24/2021
Event Type  Injury  
Event Description
Us legal bilateral patient.It was reported that after the patient underwent a revision surgery of the left hip on (b)(6) 2012, the patient underwent another revision surgery of the left hip on (b)(6) 2021 due to mechanical complication of prosthetic hip implant, osteolysis, metallosis and periprosthetic fracture.The primary left bhr was performed on (b)(6) 2009.The patient status is unknown.
 
Manufacturer Narrative
Internal complaint reference: case(b)(4).
 
Manufacturer Narrative
H3, h6.The device was not returned for evaluation and the reported event could not be confirmed.The clinical/medical investigation concluded that, with the information provided the clinical root cause of the reported elevated metal ions and intraoperative findings of metallosis, trunnionosis and greater trochanteric fracture cannot be confirmed.However, the surgical technique indicates the acetabular component is to be impacted with 15-20° of anteversion.The implantation operative report indicated the acetabular component was implanted at about 20 to 25 degrees of anteversion.It is unknown if the increased anteversion of the acetabular component led to the reported elevated metal ions and intraoperative findings of metallosis and trunnionosis.It cannot be concluded that the reported events/ clinical reactions were associated with a mal performance of the implant.The patient impact beyond the revision and expected transient post-op convalescence period cannot be determined.A review of complaint history for the previous 12 months did not reveal similar events for the listed device.A review of the instructions for use documents for total hip systems revealed that fracture, metal sensitivity reactions and/or allergic reactions to foreign materials has been identified as adverse events in primary and revision surgery.A review of the risk management file revealed this failure mode was previously identified.The anticipated risk level is still adequate.A historical review concluded that there are no prior actions related to this product and event.At this time, we have no reason to suspect that the product failed to meet any product specifications at the time of manufacture.Some potential probable causes for this event could include surgical technique, excessive forces applied to the implant, damaged product, implant corrosion or wear.The contribution of the device to the reported event could not be corroborated.Based on this investigation, the need for corrective action is not indicated.Without the return of the actual product involved, our investigation could not proceed.Should the device or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Manufacturer Narrative
The devices were not returned for evaluation; therefore, a device analysis could not be performed.The clinical/medical investigation concluded that with the information provided the clinical root cause of the reported elevated metal ions and intraoperative findings of metallosis, trunnionosis and greater trochanteric fracture cannot be confirmed.However, the surgical technique indicates the acetabular component is to be impacted with 15-20° of anteversion.The implantation operative report indicated the acetabular component was implanted at about 20 to 25 degrees of anteversion.It is unknown if the increased anteversion of the acetabular component led to the reported elevated metal ions and intraoperative findings of metallosis and trunnionosis.It cannot be concluded that the reported events/clinical reactions were associated with a mal performance of the implant.The patient impact beyond the revision and expected transient post-op convalescence period cannot be determined.The devices batch numbers were not provided, thus, an evaluation of the manufacturing records could not be performed.Also, for the anthology hip implant, as the device specific identifiers were not provided, an evaluation of the complaint history review, risk management file, and prior actions could not be performed.For the cocr modular head, a review of complaint history for 36 months did not reveal similar events for the listed device.For the titanium modular head, a review of complaint history for 36 months revealed similar events for the listed device, this failure mode will be monitored for future complaints for any necessary corrective actions.A review of the instructions for use documents for total hip systems reveals in the warnings and precautions section that congenital deformity, improper implant selection, improper broaching or reaming, osteoporosis, bone defects due to misdirected reaming, trauma, strenuous activity, improper implant alignment or placement, patient non-compliance, etc.Can increase risk of femoral or pelvic fractures.It also reveals in the adverse events in primary and revision surgery section that with all joint replacements, asymptomatic, localized, progressive bone resorption (osteolysis) may occur around the prosthetic components as a consequence of foreign-body reaction to particulate wear debris.Particles are generated by interaction between components, as well as between the components and bone, primarily through wear mechanisms of adhesion, abrasion, and fatigue.Secondarily, particles may also be generated by third-body particles lodged in the polyethylene, metal, or ceramic articular surfaces.Osteolysis can lead to future complications necessitating the removal or replacement of prosthetic components.Besides, it reveals in the postoperative warnings and precautions section that the patient should be advised to report any decrease in range of motion, squeaking, clicking, popping, grating, or grinding noises, and unusual incidences.For the cocr modular head and the titanium modular head, a review of the risk management files revealed this failure mode was previously identified.The anticipated risk level is still adequate.Besides, a historical review concluded that there are no prior actions related to these products and event.At this time, we have no evidence to conclude that the products failed to meet any specifications at the time of manufacture.Factors that could contribute to the reported event include implant corrosion, irregular implant interaction, wear, abnormal motion over time, patient condition, traumatic injury, patient medical history, and/or bone quality.Based on this investigation, the need for corrective action is not indicated.Should the devices or additional information be received, the complaint will be reopened.No further investigation is warranted for this complaint; however, we will continue to monitor for future complaints and investigate as necessary.We consider this investigation closed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
44MM COCR MODULAR HEAD
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, UNCEMENTED, METAL/POLYMER, POROUS
Manufacturer (Section D)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer (Section G)
SMITH & NEPHEW, INC.
1450 brooks rd.
memphis TN 38116
Manufacturer Contact
holly topping
7000 west william cannon drive
austin, TX 78735
5123913905
MDR Report Key13896710
MDR Text Key288318219
Report Number1020279-2022-01337
Device Sequence Number1
Product Code MBL
UDI-Device Identifier03596010652010
UDI-Public03596010652010
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K093363
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/20/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/24/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number71342644
Device Catalogue Number71342644
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/19/2022
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age57 YR
Patient SexMale
-
-